Scarica l'app Stockscreener
6.56
4.51%
-0.31
Pre-mercato:
6.18
-0.38
-5.79%
Immuneering Corp Azioni (IMRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.56%
15.48
|
18.56 | 15.27 | 14.91 | 15.33 |
| Operating Income/Loss |
16.56%
-15.48
|
-18.56 | -15.27 | -14.91 | -15.33 |
| Income/Loss From Continuing Operations Before Tax |
16.65%
-15.05
|
-18.05 | -14.60 | -14.08 | -14.31 |
| Income/Loss From Continuing Operations After Tax |
16.65%
-15.05
|
-18.05 | -14.60 | -14.08 | -14.31 |
|
Net Income/Loss
|
16.65%
-15.05
|
-18.05 | -14.60 | -14.08 | -14.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9,800%
35.53
|
0.3589 | 29.84 | 29.65 | 29.37 |
| Diluted Average Shares |
9,800%
35.53
|
0.3589 | 29.84 | 29.65 | 29.37 |
| Basic Earnings Per Share |
28.81%
-0.42
|
-0.59 | -0.49 | -0.47 | -0.49 |
| Diluted Earnings Per Share |
28.81%
-0.42
|
-0.59 | -0.49 | -0.47 | -0.49 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):